EGFL7 Antikörper (AA 1-200)
Kurzübersicht für EGFL7 Antikörper (AA 1-200) (ABIN7858436)
Target
Alle EGFL7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1-200
-
Verwendungszweck
- EGFL7 (Tumor Angiogenesis Marker) Antibody
-
Spezifität
- Epidermal growth factor (EGF) repeat-containing proteins constitute an expanding family of proteins that are involved in several cellular activities, such as blood coagulation, fibrinolysis, cell adhesion and neural and vertebrate development. A human EGF repeat superfamily member that maps to human chromosome X, EGFL6, encodes a predicted signal peptide suggesting that it is secreted. EGFL6 is expressed in brain and lung tumors and fetal tissues but is generally absent from normal adult tissues. EGFL7 is a secreted protein that regulates vascular tubulogenesis in vivo. In vitro, EGFL7 inhibits platelet-derived growth factor induced smooth muscle cell migration and promotes adhesion of endothelial cells to the substrate. EGFL7 is expressed specifically by endothelial cells of the heart, lung and kidney.
-
Aufreinigung
- 200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.
-
Immunogen
- Recombinant fragment (around aa1-200) of human EGFL7 protein (exact sequence is proprietary)
-
Isotyp
- IgG1, kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- Prepared in 10 mM PBS
-
Konservierungsmittel
- Azide free
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
-
- EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))
-
Andere Bezeichnung
- EGFL7
-
Hintergrund
-
MEGF7
293T cells. Human endometrium, tonsil, kidney or placenta.
-
Molekulargewicht
- 30kDa
-
Gen-ID
- 51162
-
UniProt
- Q9UHF1
Target
-